-
Most Popular
Uncategorized
IMCR Stock Earnings: Immunocore Hldgs Beats EPS, Beats Revenue for Q2 2024
IMCR stock results show that Immunocore Hldgs beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Qualcomm Stock Analysis: Is QCOM a Buy, Sell or Hold Right Now?
Explore Qualcomm stock and its position in the semiconductor industry, with growth potential in AI and automotive sectors.
Rivian Investors, Take Note: 2 Key Drivers That Could Boost RIVN’s Profit Outlook
Rivian stock has many upcoming, positive catalysts, meaning investors with longer investment horizons should buy Rivian stock.
What Are the Hottest Meme Stocks Right Now? 3 Top Picks.
Meme stocks – just mentioning the concept might cause eyes to roll. And that to be fair is a natural reaction. We’re all too familiar…
3 Small-Cap Stocks with Significant Growth Potential
As sector rotation continues, it could be time for investors to consider these small-cap growth stocks that institutions love.
7 Moonshot Stocks That Could Turn $10K Into $100K
These seven moonshot stocks across various sectors could turn $10,000 into $100,000 if the stars align for them.
3 Earnings Season Winners to Buy on Strength: Q2 Edition
These firms reported impressive Q2 results and even with shares rising are among the best earnings season winners to buy now.
The 3 Best Med Tech Stocks to Buy Now
Med tech firms are tremendously improving healthcare and making a great deal of money. Here are the three best med tech stocks to buy now.
7 Undervalued Stocks That Could Surge 500% in the Next 12 Months
These seven undervalued stocks across various sectors have the potential to deliver massive returns of up to 500% in the next year.
3 Stocks to Buy NOW Before the Mother of All Short Squeezes
These three short-squeeze stocks with high short interest could be primed for explosive gains if market sentiment shifts.
Oracle Stock Outlook: These 2 Positive Catalysts Will Give ORCL Shares a Lift
Oracle stock is one of the top beneficiaries of the AI and cloud transitions, suggesting it should get a big lift from its deal with OpenAI.
3 Biotech Stocks That Could Have Investors Grinning Soon
Biotech stocks are a high risk, high reward investment and these three biotechs offer significant upside potential.
Is AI “Summoning the Demon”?
Are we ready for the true cost of AGI? … what it is, and what it means … the moral gray area … “offensive” and…
3 Dividend Growth Stocks for Compounding Returns
These dividend growth stocks offer a combination of steady income and potential for capital appreciation in turbulent markets.
The Top 3 Tech Stocks to Buy Now: Summer 2024
Tech stocks were the leaders in the roaring bull market of the last two years, and some still represent a good bet for the future.
3 High-Growth Tech Stocks That Have Plenty of Lead Left In Their Pencils
These three high-growth tech stocks look poised to continue to grow into the future, and could be reasonable buys at current levels.
Mobileye (MBLY) Stock Is Down 20% as Demand Weakens. What’s Going On?
MBLY stock is tumbling 20% this morning and trending after Mobileye lowered its 2024 revenue guidance due to reduced orders from China.
Powell Greenlights a Market Surge
The Fed holds rate steady but doesn’t throw cold water on a September cut … Wall Street got the dovish Powell it wanted … Uncle…
3 Undervalued Renewable Energy Stocks to Buy for 100% Returns
These are the undervalued renewable energy stocks as they represent companies positioned for sustained growth as the backlog swells.
